Notably, treatment with an anti-HGF antibody reduced the number of circulating Tregs expressing c-MET in gastric cancer patients, underscoring HGF’s role in promoting Treg accumulation indirectly through c-MET-expressing monocytes. The gene discussed is MET; the disease is gastric cancer.